FY
Formycon
FYB.DE·XETRAMunich DEFounded 2012400 employees
Small CapbiotechPublicOphthalmologyImmunology
Platform: Biosimilar
Market Cap
$1B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (FYB.DE)
Loading FYB.DE stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| FYB-2633 | FYB-2633 | Phase 1 | 1 | MALT1 | Alzheimer'sIPF | ||
| FYB-7121 | FYB-7121 | Phase 1/2 | 1 | CD20 | AML |
SEC Filings & Financial Documents
SEC filings are not available for XETRA-listed companies.
Formycon trades on XETRA (DE). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)